VBI Vaccines Inc (57) | Uncategorized (14)

Recent Contracts

Sixth Amendment to the Collaborative Research Agreement, signed April 28, 2022, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on May 9, 2022)
First Amendment to the Collaborative Research Agreement, dated December 21, 2020, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 7, 2022)
Collaborative Research Agreement, dated March 30, 2020, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 7, 2022)
Second Amendment to the Collaborative Research Agreement, dated July 8, 2021, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 7, 2022)
Third Amendment to the Collaborative Research Agreement, dated August 27, 2021, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 7, 2022)
Fourth Amendment to the Collaborative Research Agreement, signed November 15, 2021, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 7, 2022)
Fifth Amendment Five to the Collaborative Research Agreement, signed February 8, 2022, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 7, 2022)
Amendment to the Agreement signed by NRC on March 30, 2020 and Amendment One signed by NRC on December 31, 2020 and Amendment Two signed July 8, 2021 effective August 27, 2021 (Filed With SEC on November 8, 2021)
Open Market Sale Agreement, dated September 3, 2021, by and between VBI Vaccines Inc. and Jefferies LLC (Filed With SEC on September 3, 2021)
Amendment to the Agreement signed by NRC on March 30, 2020 and Amendment One signed by NRC on December 21, 2020 effective July 8, 2021 (Filed With SEC on August 2, 2021)
Description of Securities (Filed With SEC on March 2, 2021)
Amendment One to Collaborative Research Agreement between National Research Council of Canada and Variation Biotechnologies Inc. effective December 21, 2020 (Filed With SEC on March 2, 2021)
Collaborative Research Agreement between National Research Council of Canada and Variation Biotechnologies Inc effective March 30, 2020 (Filed With SEC on May 6, 2020)
Description of Securities (Filed With SEC on March 5, 2020)